RXGEN, INC.

Company Information

Company Name
RXGEN, INC.
Address
100 DEEPWOOD DRIVE
HAMDEN, CT, 06517-
Phone
n/a
URL
n/a
DUNS
144662025
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,606,782.00
5
SBIR Phase II
$2,488,478.00
2
Chart code to be here

Award List

  1. Toxicogenomics of Hepatotoxicity in Monkeys

    Amount: $249,123.00

    DESCRIPTION (provided by applicant): SBIR Phase I Research: This proposal aims to examine the predictive utility of an in vivo primate toxicogenomic model of human hepatotoxicity. Hepatotoxicity ...

    SBIR Phase I 2004 Department of Health and Human Services
  2. Toxicogenomics of Hepatotoxicity in Monkeys

    Amount: $1,126,036.00

    DESCRIPTION (provided by applicant): SBIR Phase I Research: This proposal aims to examine the predictive utility of an in vivo primate toxicogenomic model of human hepatotoxicity. Hepatotoxicity ...

    SBIR Phase II 2005 Department of Health and Human Services
  3. Genomic markers of environmental toxins for Parkinsonism

    Amount: $227,763.00

    DESCRIPTION (provided by applicant): Parkinson's disease is a prevalent and devastating neurodegenerative condition of unknown etiology. One prominent hypothesis holds that the selective loss of the ...

    SBIR Phase I 2004 Department of Health and Human Services
  4. Ultrasound-Mediated Blood-Brain Barrier Permeabilization in Primates

    Amount: $208,554.00

    DESCRIPTION (provided by applicant): The blood-brain barrier (BBB) represents both a safeguard against the penetration of physiologically harmful substances into the central nervous system (CMS), and ...

    SBIR Phase I 2006 Department of Health and Human Services
  5. Ultrasound-Mediated Blood-Brain Barrier Permeabilization in Primates

    Amount: $1,362,442.00

    DESCRIPTION (provided by applicant): The blood-brain barrier (BBB) represents both a safeguard against the penetration of physiologically harmful substances into the central nervous system (CNS), as w ...

    SBIR Phase II 2008 Department of Health and Human Services
  6. Silencing cardiac-specific microRNAs to prevent pathological remodeling in conges

    Amount: $718,304.00

    DESCRIPTION (provided by applicant): Heart disease remains the primary cause of morbidity and mortality in the industrialized world and continues to incur costs estimated at 30 billion per year, desp ...

    SBIR Phase I 2011 Department of Health and Human Services
  7. Self-advocacy training for students with cochlear implants entering college

    Amount: $203,038.00

    Optic nerve and retinal diseases profoundly impact quality of life and overall health care burden. Demetrios Vavvas and colleagues at the Mass Eye and Ear Infirmary (MEEI) have revealed a critical red ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government